BullFrog AI Holdings BFRG
NASDAQ BFRG
$0.50 +0.01 (+2.04%)
At close: Sep 4, 2026 · 4:00 PM EDT

BullFrog AI Holdings (BFRG) Share-based Compensation (2021 - 2025)

BullFrog AI Holdings' (BFRG) quarterly Share-based Compensation came in at $154208.0 in Q4 2025, down 28.03% on a YoY basis from $214279.0 in Q4 2024, and down 82.2% quarter-over-quarter from $866412.0 in Q3 2025.

Analysis

BullFrog AI Holdings (BFRG) Share-based Compensation (2021 - 2025) Analysis & Trends

BullFrog AI Holdings (BFRG) has reported Share-based Compensation for 5 consecutive years, with $154208.0 the latest figure, recorded in Q4 2025.

  • For the quarter ending Q4 2025, Share-based Compensation fell 28.03% year-over-year to $154208.0; the trailing twelve-month figure through Dec 2025 stood at $538119.0 (up 23.58% YoY), and the FY2025 full-year result was $1.0 million, up 7.1% from the prior year.
  • Share-based Compensation slipped to $154208.0 in Q4 2025 per BFRG's latest filing, from $866412.0 in the prior quarter.
  • Across five years, Share-based Compensation topped out at $938927.0 in Q1 2025 and bottomed at $451.0 in Q2 2022.
  • Historically, Share-based Compensation has averaged $444128.2 across 5 years, with a median of $448717.0 in 2023.
  • The sharpest annual moves came in 2022 and 2023: Share-based Compensation plunged 89.48% in 2022, then soared 99393.79% in 2023.
  • Over 5 years, Share-based Compensation stood at $468571.0 in 2021, then slumped by 89.48% to $49276.0 in 2022, then surged by 144.25% to $120356.0 in 2023, then soared by 78.04% to $214279.0 in 2024, then fell by 28.03% to $154208.0 in 2025.
  • According to Business Quant data, Share-based Compensation over the past three periods registered $154208.0, $866412.0, and $938927.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Share-based Compensation (Qtr)
1 Amgen 236.37 Bn 222.38 Bn 7.24 Bn 247.00 Mn
2 Gilead Sciences 187.38 Bn 184.12 Bn 6.22 Bn 231.00 Mn
3 Vertex Pharmaceuticals 138.36 Bn 130.51 Bn 2.84 Bn 108.10 Mn
4 Regeneron Pharmaceuticals 85.09 Bn 77.10 Bn 3.93 Bn 243.00 Mn
5 Argenx Se 63.93 Bn 58.75 Bn 1.37 Bn -
6 Moderna 58.07 Bn 52.94 Bn 52.00 Mn 120.00 Mn
7 Alnylam Pharmaceuticals 35.59 Bn 32.28 Bn 992.69 Mn 86.63 Mn
8 Biogen 32.63 Bn 31.34 Bn 1.96 Bn 77.40 Mn
9 Insmed 27.57 Bn 26.41 Bn 358.27 Mn 41.25 Mn
10 BullFrog AI Holdings 9.27 Mn 2.35 Mn 106,899.00 -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 154,208.00
Sep 30, 2025 866,412.00
Jun 30, 2025 938,927.00
Mar 31, 2025 938,927.00
Dec 31, 2024 214,279.00
Sep 30, 2024 849,427.00
Jun 30, 2024 830,925.00
Mar 31, 2024 826,717.00
Dec 31, 2023 120,356.00
Sep 30, 2023 507,717.00
Jun 30, 2023 448,717.00
Mar 31, 2023 253,717.00
Dec 31, 2022 49,276.00
Sep 30, 2022 51,536.00
Jun 30, 2022 451.00
Mar 31, 2022 30,017.00
Dec 31, 2021 468,571.00